166 related articles for article (PubMed ID: 25479069)
1. Serum OPN expression for identification of gastric cancer and atrophic gastritis and its influencing factors.
Chen T; Sun L; He C; Gong Y; Xu Q; Yuan Y
PLoS One; 2014; 9(12):e114005. PubMed ID: 25479069
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of H. pylori Infection and Atrophic Gastritis in a Population-based Screening with Serum Biomarker Panel (GastroPanel®) in St. Petersburg.
Roman LD; Lukyanchuk R; Sablin OA; Araslanova EI; Eklund C; Hendolin P; Paloheimo L; Syrjänen K
Anticancer Res; 2016 Aug; 36(8):4129-38. PubMed ID: 27466521
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of serum pepsinogen I , II and osteopontin co-detection in gastric cancer screening].
Gong YH; Sun LP; Yuan Y
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):691-3. PubMed ID: 17274377
[TBL] [Abstract][Full Text] [Related]
4. LncRNAs adjacent to pepsinogen C in gastric diseases and diagnostic efficiencies of joint detection in gastric diseases.
Liu WJ; Lv Z; Liu JW; Xu Q; Ding HX; Yuan Y
Future Oncol; 2020 Apr; 16(11):655-663. PubMed ID: 32242461
[No Abstract] [Full Text] [Related]
5. Stepwise cumulation of RUNX3 methylation mediated by Helicobacter pylori infection contributes to gastric carcinoma progression.
Lu XX; Yu JL; Ying LS; Han J; Wang S; Yu QM; Wang XB; Fang XH; Ling ZQ
Cancer; 2012 Nov; 118(22):5507-17. PubMed ID: 22576578
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive evaluation of fasting serum gastrin-17 as a predictor of diseased stomach in Chinese population.
Sun L; Tu H; Liu J; Gong Y; Xu Q; Jing J; Dong N; Yuan Y
Scand J Gastroenterol; 2014 Oct; 49(10):1164-72. PubMed ID: 25157583
[TBL] [Abstract][Full Text] [Related]
7. Promoter methylation of RNF180 is associated with H.pylori infection and serves as a marker for gastric cancer and atrophic gastritis.
Han F; Sun LP; Liu S; Xu Q; Liang QY; Zhang Z; Cao HC; Yu J; Fan DM; Nie YZ; Wu KC; Yuan Y
Oncotarget; 2016 Apr; 7(17):24800-9. PubMed ID: 27050149
[TBL] [Abstract][Full Text] [Related]
8. PGC TagSNP and its interaction with H. pylori and relation with gene expression in susceptibility to gastric carcinogenesis.
He CY; Sun LP; Xu Q; Liu JW; Jiang JY; Dong NN; Yuan Y
PLoS One; 2014; 9(12):e115955. PubMed ID: 25551587
[TBL] [Abstract][Full Text] [Related]
9. The association between precancerous gastric lesions and serum pepsinogens, serum gastrin, vascular endothelial growth factor, serum interleukin-1 Beta, serum toll-like receptor-4 levels and Helicobacter pylori Cag A status.
Yakut M; Örmeci N; Erdal H; Keskin O; Karayel Z; Tutkak H; Soykan I
Clin Res Hepatol Gastroenterol; 2013 Jun; 37(3):302-11. PubMed ID: 23137754
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of H. pylori infection and atrophic gastritis among symptomatic and dyspeptic adults in Kazakhstan. A hospital-based screening study using a panel of serum biomarkers.
Benberin V; Bektayeva R; Karabayeva R; Lebedev A; Akemeyeva K; Paloheimo L; Syrjänen K
Anticancer Res; 2013 Oct; 33(10):4595-602. PubMed ID: 24123036
[TBL] [Abstract][Full Text] [Related]
11. Serum miR-101-3p combined with pepsinogen contributes to the early diagnosis of gastric cancer.
Zeng W; Zhang S; Yang L; Wei W; Gao J; Guo N; Wu F
BMC Med Genet; 2020 Feb; 21(1):28. PubMed ID: 32041551
[TBL] [Abstract][Full Text] [Related]
12. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
Yoshida T; Kato J; Inoue I; Yoshimura N; Deguchi H; Mukoubayashi C; Oka M; Watanabe M; Enomoto S; Niwa T; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Takeshita T; Ushijima T; Ichinose M
Int J Cancer; 2014 Mar; 134(6):1445-57. PubMed ID: 24009139
[TBL] [Abstract][Full Text] [Related]
13. ABO genotype and the risk of gastric cancer, atrophic gastritis, and Helicobacter pylori infection.
Nakao M; Matsuo K; Ito H; Shitara K; Hosono S; Watanabe M; Ito S; Sawaki A; Iida S; Sato S; Yatabe Y; Yamao K; Ueda R; Tajima K; Hamajima N; Tanaka H
Cancer Epidemiol Biomarkers Prev; 2011 Aug; 20(8):1665-72. PubMed ID: 21680535
[TBL] [Abstract][Full Text] [Related]
14. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
Cao Q; Ran ZH; Xiao SD
J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
[TBL] [Abstract][Full Text] [Related]
15. Relationship between Helicobacter pylori infection, atrophic gastritis and gastric carcinoma in a Japanese population.
Asaka M; Kato M; Kudo M; Katagiri M; Nishikawa K; Yoshida J; Takeda H; Miki K
Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S7-10. PubMed ID: 8574741
[TBL] [Abstract][Full Text] [Related]
16. Follow-up study on a high risk population of gastric cancer in north China by serum pepsinogen assay.
Sun LP; Gong YH; Wang L; Gong W; Yuan Y
J Dig Dis; 2008 Feb; 9(1):20-6. PubMed ID: 18251790
[TBL] [Abstract][Full Text] [Related]
17. [Serological assessment of Helicobacter pylori-specific antibodies and their association with gastric lesions in a high-risk population].
Liu C; Wang YM; Li ZX; Zhang L; Ma JL; Zhou T; You WC; Pan KF
Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):547-51. PubMed ID: 24257311
[TBL] [Abstract][Full Text] [Related]
18. [Helicobacter pylori and the progression of gastric cancer: a 10-year cohort study].
Ma JL; Zhang L; Pan KF; Liu WD; Feng GS; You WC
Zhonghua Yi Xue Za Zhi; 2005 Oct; 85(39):2758-61. PubMed ID: 16324316
[TBL] [Abstract][Full Text] [Related]
19. Association of MTOR and AKT Gene Polymorphisms with Susceptibility and Survival of Gastric Cancer.
Piao Y; Li Y; Xu Q; Liu JW; Xing CZ; Xie XD; Yuan Y
PLoS One; 2015; 10(8):e0136447. PubMed ID: 26317520
[TBL] [Abstract][Full Text] [Related]
20. Promoter polymorphisms in trefoil factor 2 and trefoil factor 3 genes and susceptibility to gastric cancer and atrophic gastritis among Chinese population.
Xu Q; Chen MY; He CY; Sun LP; Yuan Y
Gene; 2013 Oct; 529(1):104-12. PubMed ID: 23933418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
